Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.841 USD | -2.21% | -6.11% | -37.41% |
May. 15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Top Premarket Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-37.41% | 3.28M | |
-6.60% | 178B | |
-0.49% | 107B | |
-1.53% | 67.04B | |
-6.77% | 47.23B | |
+11.30% | 44.62B | |
+9.25% | 42.5B | |
+15.75% | 29.99B | |
+15.97% | 25.22B | |
-5.97% | 24.14B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- Transcript : INVO Bioscience, Inc., Q4 2022 Earnings Call, Apr 17, 2023